
Showing 21 - 40 of 98 results
ANSTO’s experts build new knowledge, drive innovation and support training and development for the safe management of Australia's radioactive waste
ANSTO has almost seventy years of experience in advancing an understanding of the management of spent nuclear fuel and delivering safe and reliable forms for radioactive waste.
Australia's nuclear agency welcomes 2015/16 budget
Cancer patients to benefit from new supply chain
OPAL reactor back in business
Successful Repatriation of Australia's Radioactive Waste
The Australian Government’s nuclear agency, ANSTO, together with NSW Police and multiple state and federal authorities, has completed an operation to repatriate radioactive waste from the UK.
Going global with nuclear medicine
New Joint Venture to manufacture GMP theranostic radiopharmaceuticals in Australia
Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australia’s first GMP (Good Manufacturing Practice) theranostics facility starting in Melbourne, Australia.
Australia completes first phase of its waste repatriation project
Australia's nuclear agency welcomes SA mayors and CEOs
Licence awarded
Australia’s new state-of-the-art nuclear medicine facility gets green light.
Update: Nuclear medicine production
Update on Nuclear medicine production at ANSTO.

Update on building 23 at ANSTO
The Australian Government recently announced $30 million to design a new world-leading nuclear medicine manufacturing facility at ANSTO’s Lucas Heights campus, and replace and an ageing facility.
Declaration of the national radioactive waste management facility in South Australia is an important outcome for Australia
A site for the National Radioactive Waste Management Facility has been acquired, with the new facility to be built near the town of Kimba on the South Australian Eyre Peninsula.
ANSTO fights cancer
Commitment to undertake health research.
Radioactive waste briefing for Nuclear Medicine Specialists
Seven of Australia’s top nuclear medicine professionals have been briefed on ANSTO’s plans to manage radioactive waste, as well as to support nuclear medicine innovation in Australia.
License to produce Lutetium-177 for clinical trials
ANSTO is proud to announce that a license has been issued by the Therapeutic Goods Administration to produce Lutetium-177 (Lu-177) for use in clinical trials.
Leveraging over half a century of knowledge in the safe management of radioactive waste
ANSTO's Chief Nuclear Officer shares insights on the safe management of Australia's nuclear waste.
10th birthday of OPAL nuclear research reactor marks a decade of research

Our History
In April 15, 1953, Australia entered the nuclear science arena, when the Atomic Energy Act came into effect. The Australian Atomic Energy Commission (AAEC) followed and in 1987 the AAEC evolved into the Australian Nuclear Science and Technology Organisation (ANSTO) as it’s known today.